Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MedImmune

Founders Wayne Hockmeyer

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$33M
Portfolio companies 3
Rounds per year 0.09
Lead investments 0
Exits 2
Key employees Soon

Areas of investment

  • Therapeutics
  • Medical
  • Biotechnology
  • Education
  • Innovation Management
Summary

In 1987 was created MedImmune, which is appeared as Corporate Investor. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Maryland.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the MedImmune, startups are often financed by Sofinnova Partners, Apple Tree Partners. The meaningful sponsors for the fund in investment in the same round are Venrock Healthcare Partners, Venrock, Sofinnova Partners. In the next rounds fund is usually obtained by Auven Therapeutics, AstraZeneca, Redmile Group.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Corvidia Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Genetics, Medical.

The top activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.

This organization was formed by Wayne Hockmeyer.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AlphaCoin Fund Boston, Massachusetts, United States
Arcadia Funds Burlington, Massachusetts, United States
BERRIUP Autonomous Community of the Basque Country, San Sebastián, Spain
Bitrise Capital Central, Central Region, Singapore
Boyue Changxing Industrial China, Hubei, Wuhan Shi
Chengdu Mengting Electronic Commerce Chengdu, China, Sichuan
CoFound Partners New York, New York, United States
Dongzhao Shanghai Group -
Jinsheng Capital -
Klinkert Investment Trust -
Laconia New York, New York, United States
Litera Investments Canada, London, Ontario
London Startup Society England, London, United Kingdom
New Wheel Capital -
SC Digital Media Japan, Tokyo
Shoko Chukin Bank New York, New York, United States
Sorenson Development -
SSE Australia, Perth, Western Australia
Xizang Tongmei Wenhua Chengguan District, China, Lhasa

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Corvidia

Biotechnology
Genetics
Health Care
Medical
Therapeutics
$60M25 Apr 2018 Massachusetts, United States

ADC Therapeutics

Biopharma
Biotechnology
Medical
Therapeutics
$40M16 Oct 2013 Lausanne, Vaud, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MedImmune?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 33M
Rounds per year 0.09
Peak activity year 2014
Lead investments 0
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Corvidia

Biotechnology
Genetics
Health Care
Medical
Therapeutics
$60M25 Apr 2018 Massachusetts, United States

ADC Therapeutics

Biopharma
Biotechnology
Medical
Therapeutics
$40M16 Oct 2013 Lausanne, Vaud, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: